US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lexeo Therapeutics

4.88

-0.1800-3.56%

Post-market: 4.80-0.0800-1.64%19:30 EDT

Volume:509.59K

Turnover:2.55M

Market Cap:400.39M

PE:-4.26

High:5.20

Open:5.12

Low:4.84

Close:5.06

52wk High:10.99

52wk Low:3.99

Shares:82.05M

Float Shares:51.24M

Volume Ratio:0.59

T/O Rate:0.99%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.1457

EPS(LYR):-1.8634

ROE:-46.76%

ROA:-27.59%

PB:1.70

PE(LYR):-2.62

Loading ...

Overview Company News Filings

Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia

Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference

Lexeo Therapeutics, Inc. (LXEO) Gets a Buy from RBC Capital

Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Lexeo Therapeutics, Inc. (LXEO)

Lexeo Therapeutics Is Maintained at Buy by Chardan Capital

Lexeo Therapeutics reports Q1 EPS (25c), consensus (30c)

Lexeo Therapeutics Q1 EPS $(0.25) Beats $(0.33) Estimate, Cash, Cash Equivalents And Investments Of $227.6M Expected To Provide Operational Runway Into 2028

Benzinga Earnings

Lexeo Q1 FY26 net loss narrows to $20.2 million, or $0.25 a share

Press Release: Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights

Lexeo Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview

Lexeo Therapeutics appoints Laura Sepp-Lorenzino to board

Lexeo Therapeutics announces annual shareholder meeting

Lexeo to present new gene therapy and AAV manufacturing data at ASGCT meeting

Lexeo Therapeutics Announces Multiple Presentations at the 29TH American Society of Gene & Cell Therapy (Asgct) Annual Meeting

THOMSON REUTERS

Lexeo CEO Richard Nolan Townsend disposes of 55,000 shares worth $313,137

Oppenheimer Reaffirms Their Buy Rating on Lexeo Therapeutics, Inc. (LXEO)

Lexeo Therapeutics, Inc. (LXEO) Gets a Buy from RBC Capital

Lexeo Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Lexeo Therapeutics Advances Cardiac Gene Therapies, Strengthens Finances

Lexeo Therapeutics Q4 EPS $(0.27) Beats $(0.34) Estimate

Benzinga Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LXEO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LXEO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LXEO\",,,,,undefined,":{"symbol":"LXEO","market":"US","secType":"STK","nameCN":"Lexeo Therapeutics","latestPrice":4.88,"timestamp":1787342400000,"preClose":5.06,"halted":0,"volume":509587,"hourTrading":{"tag":"盘后","latestPrice":4.8,"preClose":4.88,"latestTime":"19:30 EDT","volume":10882,"amount":52789.82,"timestamp":1787355006637,"change":-0.08,"changeRate":-0.016393,"amplitude":0.020492},"delay":0,"changeRate":-0.035573122529644216,"floatShares":51240200,"shares":82046255,"eps":-1.145694,"marketStatus":"Market Closed","change":-0.18,"latestTime":"08-21 16:00:00 EDT","open":5.12,"high":5.204,"low":4.84,"amount":2551826.9707125,"amplitude":0.071937,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.145694,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1698984000000,"exchange":"NASDAQ","adjPreClose":5.06,"preHourTrading":{"tag":"盘前","latestPrice":5.06,"preClose":5.06,"latestTime":"08:45 EDT","volume":463,"amount":2331.5497961,"timestamp":1787316356512,"change":0,"changeRate":0,"amplitude":0.197628},"postHourTrading":{"tag":"盘后","latestPrice":4.8,"preClose":4.88,"latestTime":"19:30 EDT","volume":10882,"amount":52789.82,"timestamp":1787355006637,"change":-0.08,"changeRate":-0.016393,"amplitude":0.020492},"volumeRatio":0.5931124111843442,"impliedVol":0.3472,"impliedVolPercentile":0.0478},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LXEO\",,,,,undefined,":{"symbol":"LXEO","floatShares":51240200,"roa":"-27.59%","roe":"-46.76%","lyrEps":-1.863368,"volumeRatio":0.5931124111843442,"shares":82046255,"dividePrice":0,"high":5.204,"amplitude":0.071937,"preClose":5.06,"low":4.84,"week52Low":3.99,"pbRate":"1.70","week52High":10.99,"institutionHeld":0,"latestPrice":4.88,"eps":-1.145694,"divideRate":0,"volume":509587,"delay":0,"ttmEps":-1.145694,"open":5.12,"prevYearClose":9.93,"prevWeekClose":4.84,"prevMonthClose":4.13,"prevQuarterClose":4.655,"fiveDayClose":4.84,"twentyDayClose":4.66,"sixtyDayClose":5.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LXEO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"LXEO","fiscalQuarterEnding":"2026/06","expectedEps":-0.3,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"pre","actualEps":-0.3},{"market":"US","date":"2026-05-11","symbol":"LXEO","fiscalQuarterEnding":"2026/03","expectedEps":-0.29,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"pre","actualEps":-0.25},{"market":"US","date":"2026-03-30","symbol":"LXEO","fiscalQuarterEnding":"2025/12","expectedEps":-0.32,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2025-11-05","symbol":"LXEO","fiscalQuarterEnding":"2025/09","expectedEps":-0.48,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.33},{"market":"US","date":"2025-08-14","symbol":"LXEO","fiscalQuarterEnding":"2025/06","expectedEps":-0.64,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LXEO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LXEO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":10,"updateTime":1766030400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LXEO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LXEO","date":"2026-08-21","current":-4.259427,"percent":0.39028,"low":-8.903248,"twenty":-6.046619,"median":-4.295552,"eighty":-2.242638,"high":-0.6043,"avg":-4.181489,"sd":1.908285,"marketCap":415134685},"quantilePoints":[{"date":"2023-11-03","current":-4.257819,"twenty":-4.257819,"median":-4.257819,"eighty":-4.257819,"marketCap":271355051},{"date":"2023-11-10","current":-4.199758,"twenty":-4.199758,"median":-4.091377,"eighty":-4.048799,"marketCap":267654754},{"date":"2023-11-17","current":-4.292656,"twenty":-4.257819,"median":-4.118472,"eighty":-4.064282,"marketCap":273575228},{"date":"2023-11-24","current":-4.373941,"twenty":-4.270979,"median":-4.199758,"eighty":-4.070475,"marketCap":278755643},{"date":"2023-12-01","current":-4.923587,"twenty":-4.377038,"median":-4.259754,"eighty":-4.081313,"marketCap":313785113},{"date":"2023-12-08","current":-5.031968,"twenty":-4.945263,"median":-4.26556,"eighty":-4.111505,"marketCap":320692333},{"date":"2023-12-15","current":-4.58828,"twenty":-4.855461,"median":-4.333298,"eighty":-4.161824,"marketCap":306423687},{"date":"2023-12-22","current":-5.849059,"twenty":-5.408075,"median":-4.389424,"eighty":-4.194339,"marketCap":390623587},{"date":"2023-12-29","current":-5.805172,"twenty":-5.505138,"median":-4.537237,"eighty":-4.207282,"marketCap":387692577},{"date":"2024-01-05","current":-5.857039,"twenty":-5.805172,"median":-4.621669,"eighty":-4.218567,"marketCap":391156497},{"date":"2024-01-12","current":-5.896937,"twenty":-5.857039,"median":-4.799136,"eighty":-4.257819,"marketCap":393821051},{"date":"2024-01-19","current":-6.012642,"twenty":-5.955803,"median":-4.957419,"eighty":-4.257819,"marketCap":401548257},{"date":"2024-01-26","current":-6.66298,"twenty":-6.148663,"median":-5.403559,"eighty":-4.260916,"marketCap":444980484},{"date":"2024-02-02","current":-6.706868,"twenty":-6.322251,"median":-5.468033,"eighty":-4.26169,"marketCap":447911493},{"date":"2024-02-09","current":-6.714848,"twenty":-6.590366,"median":-5.777243,"eighty":-4.264786,"marketCap":448444404},{"date":"2024-02-16","current":-6.072489,"twenty":-6.589568,"median":-5.827115,"eighty":-4.287237,"marketCap":405545088},{"date":"2024-02-23","current":-6.343796,"twenty":-6.544084,"median":-5.876988,"eighty":-4.341427,"marketCap":423664054},{"date":"2024-03-01","current":-5.8331,"twenty":-6.543286,"median":-5.916886,"eighty":-4.373941,"marketCap":389557765},{"date":"2024-03-08","current":-5.857039,"twenty":-6.520145,"median":-5.890953,"eighty":-4.383231,"marketCap":391156497},{"date":"2024-03-15","current":-6.292966,"twenty":-6.520145,"median":-5.916886,"eighty":-4.447485,"marketCap":417815207},{"date":"2024-03-22","current":-6.028084,"twenty":-6.505782,"median":-5.977118,"eighty":-4.547445,"marketCap":400228597},{"date":"2024-03-28","current":-6.128418,"twenty":-6.497802,"median":-5.937219,"eighty":-4.601636,"marketCap":406890192},{"date":"2024-04-05","current":-5.265543,"twenty":-6.474661,"median":-5.932845,"eighty":-4.625869,"marketCap":349600479},{"date":"2024-04-12","current":-5.241463,"twenty":-6.410602,"median":-5.90231,"eighty":-4.683238,"marketCap":348001696},{"date":"2024-04-19","current":-4.844139,"twenty":-6.359022,"median":-5.876988,"eighty":-4.791277,"marketCap":321621782},{"date":"2024-04-26","current":-4.88026,"twenty":-6.350977,"median":-5.858281,"eighty":-4.83704,"marketCap":324019956},{"date":"2024-05-03","current":-6.182772,"twenty":-6.32828,"median":-5.876988,"eighty":-4.840714,"marketCap":410498948},{"date":"2024-05-10","current":-6.881509,"twenty":-6.410602,"median":-5.90231,"eighty":-4.84735,"marketCap":477707444},{"date":"2024-05-17","current":-6.653707,"twenty":-6.497802,"median":-5.932845,"eighty":-4.860193,"marketCap":461893680},{"date":"2024-05-24","current":-7.346604,"twenty":-6.546981,"median":-6.018356,"eighty":-4.875444,"marketCap":509993878},{"date":"2024-05-31","current":-7.617118,"twenty":-6.584345,"median":-6.028342,"eighty":-4.885879,"marketCap":528772723},{"date":"2024-06-07","current":-8.28154,"twenty":-6.629029,"median":-6.03658,"eighty":-4.908353,"marketCap":574896200},{"date":"2024-06-14","current":-8.903248,"twenty":-6.66298,"median":-6.072489,"eighty":-4.908353,"marketCap":618054597},{"date":"2024-06-21","current":-7.441521,"twenty":-6.711656,"median":-6.103378,"eighty":-4.917985,"marketCap":516582946},{"date":"2024-06-28","current":-7.05236,"twenty":-6.714848,"median":-6.103378,"eighty":-4.921032,"marketCap":489567767},{"date":"2024-07-05","current":-7.066597,"twenty":-6.782675,"median":-6.120366,"eighty":-4.923587,"marketCap":490556127},{"date":"2024-07-12","current":-8.276794,"twenty":-6.842522,"median":-6.15029,"eighty":-4.991251,"marketCap":574566747},{"date":"2024-07-15","current":-8.352728,"twenty":-6.873712,"median":-6.156275,"eighty":-4.995541,"marketCap":579838001},{"date":"2024-08-02","current":-6.198104,"twenty":-6.865914,"median":-6.161186,"eighty":-4.999831,"marketCap":430266153},{"date":"2024-08-09","current":-5.54792,"twenty":-6.840926,"median":-6.144305,"eighty":-5.014306,"marketCap":385131036},{"date":"2024-08-16","current":-5.180835,"twenty":-6.826318,"median":-6.112265,"eighty":-5.010821,"marketCap":400038148},{"date":"2024-08-23","current":-5.215088,"twenty":-6.797868,"median":-6.103378,"eighty":-5.014306,"marketCap":402683028},{"date":"2024-08-30","current":-4.975314,"twenty":-6.782675,"median":-6.066504,"eighty":-4.996865,"marketCap":384168866},{"date":"2024-09-06","current":-4.881117,"twenty":-6.774695,"median":-6.03259,"eighty":-4.924513,"marketCap":376895445},{"date":"2024-09-13","current":-4.22602,"twenty":-6.738787,"median":-6.028084,"eighty":-4.89684,"marketCap":326312109},{"date":"2024-09-20","current":-4.461512,"twenty":-6.721232,"median":-5.996218,"eighty":-4.873838,"marketCap":344495661},{"date":"2024-09-27","current":-3.814978,"twenty":-6.714848,"median":-5.932845,"eighty":-4.83926,"marketCap":294573545},{"date":"2024-10-04","current":-3.900612,"twenty":-6.71405,"median":-5.90231,"eighty":-4.736975,"marketCap":301185746},{"date":"2024-10-11","current":-3.408218,"twenty":-6.71006,"median":-5.876988,"eighty":-4.623769,"marketCap":263165591},{"date":"2024-10-18","current":-3.89633,"twenty":-6.698313,"median":-5.858281,"eighty":-4.466448,"marketCap":300855136},{"date":"2024-10-25","current":-4.238865,"twenty":-6.663872,"median":-5.849059,"eighty":-4.397847,"marketCap":327303939},{"date":"2024-10-31","current":-3.543091,"twenty":-6.66298,"median":-5.819389,"eighty":-4.373941,"marketCap":273579808},{"date":"2024-11-08","current":-3.378247,"twenty":-6.65417,"median":-5.783228,"eighty":-4.26556,"marketCap":260851321},{"date":"2024-11-15","current":-2.970727,"twenty":-6.653707,"median":-5.678921,"eighty":-4.257819,"marketCap":257253067},{"date":"2024-11-22","current":-2.367417,"twenty":-6.629978,"median":-5.544882,"eighty":-4.208893,"marketCap":205008871},{"date":"2024-11-29","current":-3.142556,"twenty":-6.626181,"median":-5.512207,"eighty":-4.166207,"marketCap":272132743},{"date":"2024-12-06","current":-2.703438,"twenty":-6.607553,"median":-5.450079,"eighty":-4.100138,"marketCap":234106904},{"date":"2024-12-13","current":-2.72253,"twenty":-6.599941,"median":-5.414849,"eighty":-4.066934,"marketCap":235760202},{"date":"2024-12-20","current":-2.306323,"twenty":-6.589568,"median":-5.281597,"eighty":-3.914314,"marketCap":199718319},{"date":"2024-12-27","current":-2.588885,"twenty":-6.578686,"median":-5.241463,"eighty":-3.893837,"marketCap":224187120},{"date":"2025-01-03","current":-2.546883,"twenty":-6.570706,"median":-5.215088,"eighty":-3.826967,"marketCap":220549866},{"date":"2025-01-10","current":-2.604159,"twenty":-6.564766,"median":-5.210806,"eighty":-3.754178,"marketCap":225509758},{"date":"2025-01-17","current":-1.981757,"twenty":-6.550955,"median":-5.17013,"eighty":-3.659982,"marketCap":171612264},{"date":"2025-01-24","current":-2.142882,"twenty":-6.53506,"median":-5.110187,"eighty":-3.528106,"marketCap":185565027},{"date":"2025-01-31","current":-2.005371,"twenty":-6.527327,"median":-5.031968,"eighty":-3.425345,"marketCap":173657111},{"date":"2025-02-07","current":-2.070307,"twenty":-6.515357,"median":-5.011134,"eighty":-3.395373,"marketCap":179280293},{"date":"2025-02-14","current":-1.611936,"twenty":-6.499398,"median":-4.991251,"eighty":-3.192195,"marketCap":139587239},{"date":"2025-02-21","current":-1.539361,"twenty":-6.496206,"median":-4.928215,"eighty":-3.10819,"marketCap":133302506},{"date":"2025-02-28","current":-1.142107,"twenty":-6.453914,"median":-4.914373,"eighty":-2.892068,"marketCap":98901859},{"date":"2025-03-07","current":-1.073351,"twenty":-6.437026,"median":-4.893962,"eighty":-2.779043,"marketCap":92947901},{"date":"2025-03-14","current":-1.134467,"twenty":-6.376035,"median":-4.880688,"eighty":-2.703438,"marketCap":98240308},{"date":"2025-03-21","current":-1.027514,"twenty":-6.356851,"median":-4.852166,"eighty":-2.601104,"marketCap":88978596},{"date":"2025-03-28","current":-1.387527,"twenty":-6.34619,"median":-4.840506,"eighty":-2.545356,"marketCap":136439657},{"date":"2025-04-04","current":-0.891258,"twenty":-6.338037,"median":-4.795483,"eighty":-2.464405,"marketCap":87640072},{"date":"2025-04-11","current":-0.732587,"twenty":-6.311324,"median":-4.74555,"eighty":-2.42393,"marketCap":72037483},{"date":"2025-04-17","current":-0.769723,"twenty":-6.30019,"median":-4.649906,"eighty":-2.355198,"marketCap":75689153},{"date":"2025-04-25","current":-1.238984,"twenty":-6.294572,"median":-4.621669,"eighty":-2.271508,"marketCap":121832978},{"date":"2025-05-02","current":-1.590085,"twenty":-6.292966,"median":-4.546304,"eighty":-2.190247,"marketCap":156357855},{"date":"2025-05-09","current":-1.012793,"twenty":-6.292343,"median":-4.461512,"eighty":-2.110502,"marketCap":99590991},{"date":"2025-05-16","current":-0.81978,"twenty":-6.289736,"median":-4.386933,"eighty":-1.999259,"marketCap":89607702},{"date":"2025-05-23","current":-0.935157,"twenty":-6.278497,"median":-4.373941,"eighty":-1.883139,"marketCap":102219157},{"date":"2025-05-30","current":-0.871396,"twenty":-6.262715,"median":-4.292656,"eighty":-1.737224,"marketCap":95249669},{"date":"2025-06-06","current":-0.992845,"twenty":-6.24372,"median":-4.263625,"eighty":-1.61652,"marketCap":108524884},{"date":"2025-06-13","current":-2.052375,"twenty":-6.232879,"median":-4.257819,"eighty":-1.598825,"marketCap":224338921},{"date":"2025-06-20","current":-2.127645,"twenty":-6.223303,"median":-4.238865,"eighty":-1.614228,"marketCap":232566510},{"date":"2025-06-27","current":-2.06491,"twenty":-6.203846,"median":-4.21373,"eighty":-1.629508,"marketCap":225709077},{"date":"2025-07-03","current":-2.198289,"twenty":-6.20262,"median":-4.195762,"eighty":-1.653954,"marketCap":240288372},{"date":"2025-07-11","current":-2.267449,"twenty":-6.200163,"median":-4.140386,"eighty":-1.70361,"marketCap":247848006},{"date":"2025-07-18","current":-2.104429,"twenty":-6.198104,"median":-4.103992,"eighty":-1.718889,"marketCap":230028868},{"date":"2025-07-25","current":-1.812971,"twenty":-6.182772,"median":-4.083635,"eighty":-1.764727,"marketCap":198170410},{"date":"2025-08-01","current":-2.336608,"twenty":-6.17781,"median":-4.06594,"eighty":-1.812971,"marketCap":255407640},{"date":"2025-08-08","current":-2.198289,"twenty":-6.166096,"median":-4.041907,"eighty":-1.86404,"marketCap":240288372},{"date":"2025-08-15","current":-2.26542,"twenty":-6.156275,"median":-3.900612,"eighty":-1.87168,"marketCap":258647483},{"date":"2025-08-22","current":-2.26069,"twenty":-6.144305,"median":-3.890098,"eighty":-1.890778,"marketCap":258107509},{"date":"2025-08-29","current":-2.251231,"twenty":-6.128418,"median":-3.827824,"eighty":-1.92165,"marketCap":257027562},{"date":"2025-09-05","current":-2.35055,"twenty":-6.121976,"median":-3.799992,"eighty":-1.925602,"marketCap":268367013},{"date":"2025-09-12","current":-2.449869,"twenty":-6.107404,"median":-3.74219,"eighty":-1.93461,"marketCap":279706464},{"date":"2025-09-19","current":-2.582295,"twenty":-6.103535,"median":-3.677964,"eighty":-1.952307,"marketCap":294825733},{"date":"2025-09-26","current":-3.07416,"twenty":-6.103378,"median":-3.543091,"eighty":-1.960886,"marketCap":350983015},{"date":"2025-10-03","current":-3.16875,"twenty":-6.084882,"median":-3.508838,"eighty":-1.966064,"marketCap":361782492},{"date":"2025-10-10","current":-3.878171,"twenty":-6.074043,"median":-3.510979,"eighty":-1.967068,"marketCap":442778573},{"date":"2025-10-17","current":-4.147751,"twenty":-6.062913,"median":-3.59126,"eighty":-1.975097,"marketCap":473557083},{"date":"2025-10-24","current":-4.256529,"twenty":-6.041368,"median":-3.707936,"eighty":-1.980826,"marketCap":485976483},{"date":"2025-10-31","current":-5.750439,"twenty":-6.046619,"median":-3.744331,"eighty":-1.985047,"marketCap":656539109},{"date":"2025-11-07","current":-5.854784,"twenty":-6.046619,"median":-3.79777,"eighty":-1.986886,"marketCap":614553293},{"date":"2025-11-14","current":-6.25113,"twenty":-6.074043,"median":-3.827824,"eighty":-1.989502,"marketCap":656156069},{"date":"2025-11-21","current":-6.195502,"twenty":-6.104132,"median":-3.878171,"eighty":-2.002315,"marketCap":650317083},{"date":"2025-11-28","current":-6.856078,"twenty":-6.134773,"median":-3.890098,"eighty":-2.017382,"marketCap":719655044},{"date":"2025-12-05","current":-6.320664,"twenty":-6.150597,"median":-3.89885,"eighty":-2.031318,"marketCap":663454802},{"date":"2025-12-12","current":-6.814357,"twenty":-6.187864,"median":-3.917739,"eighty":-2.03527,"marketCap":715275804},{"date":"2025-12-19","current":-6.925612,"twenty":-6.202522,"median":-4.030982,"eighty":-2.038234,"marketCap":726953776},{"date":"2025-12-26","current":-7.342817,"twenty":-6.232879,"median":-4.056541,"eighty":-2.044162,"marketCap":770746173},{"date":"2026-01-02","current":-6.904752,"twenty":-6.267809,"median":-4.06981,"eighty":-2.050547,"marketCap":724764157},{"date":"2026-01-09","current":-6.584894,"twenty":-6.292758,"median":-4.093288,"eighty":-2.054882,"marketCap":691189986},{"date":"2026-01-16","current":-5.215069,"twenty":-6.292758,"median":-4.112303,"eighty":-2.065989,"marketCap":547404952},{"date":"2026-01-23","current":-5.340231,"twenty":-6.291928,"median":-4.144069,"eighty":-2.070307,"marketCap":560542671},{"date":"2026-01-30","current":-5.263743,"twenty":-6.288275,"median":-4.176128,"eighty":-2.074127,"marketCap":552514065},{"date":"2026-02-06","current":-4.79091,"twenty":-6.285897,"median":-4.204325,"eighty":-2.07973,"marketCap":502882683},{"date":"2026-02-13","current":-4.568401,"twenty":-6.271979,"median":-4.22602,"eighty":-2.08467,"marketCap":479526738},{"date":"2026-02-20","current":-4.359798,"twenty":-6.2553,"median":-4.256529,"eighty":-2.093982,"marketCap":457630540},{"date":"2026-02-27","current":-4.797864,"twenty":-6.249281,"median":-4.259754,"eighty":-2.101306,"marketCap":503612556},{"date":"2026-03-06","current":-4.700516,"twenty":-6.238621,"median":-4.26556,"eighty":-2.104054,"marketCap":493394330},{"date":"2026-03-13","current":-4.610121,"twenty":-6.229687,"median":-4.302155,"eighty":-2.104429,"marketCap":483905978},{"date":"2026-03-20","current":-4.026033,"twenty":-6.20894,"median":-4.311653,"eighty":-2.110959,"marketCap":422596623},{"date":"2026-03-27","current":-3.928685,"twenty":-6.202926,"median":-4.267198,"eighty":-2.118489,"marketCap":412378397},{"date":"2026-04-02","current":-4.202375,"twenty":-6.202522,"median":-4.26169,"eighty":-2.124573,"marketCap":420073647},{"date":"2026-04-10","current":-4.765657,"twenty":-6.20108,"median":-4.26556,"eighty":-2.129912,"marketCap":476379815},{"date":"2026-04-17","current":-4.876831,"twenty":-6.198928,"median":-4.284574,"eighty":-2.138298,"marketCap":487492874},{"date":"2026-04-24","current":-4.45437,"twenty":-6.196543,"median":-4.359798,"eighty":-2.158925,"marketCap":445263248},{"date":"2026-05-01","current":-4.220904,"twenty":-6.187864,"median":-4.308896,"eighty":-2.183857,"marketCap":421925823},{"date":"2026-05-08","current":-4.313549,"twenty":-6.179795,"median":-4.311653,"eighty":-2.193349,"marketCap":431186706},{"date":"2026-05-15","current":-4.935589,"twenty":-6.170782,"median":-4.347791,"eighty":-2.193349,"marketCap":431868987},{"date":"2026-05-22","current":-4.693297,"twenty":-6.160203,"median":-4.359798,"eighty":-2.196313,"marketCap":410668145},{"date":"2026-05-29","current":-4.55869,"twenty":-6.152489,"median":-4.365307,"eighty":-2.198289,"marketCap":398889900},{"date":"2026-06-05","current":-4.289476,"twenty":-6.145809,"median":-4.360188,"eighty":-2.198289,"marketCap":375333410},{"date":"2026-06-12","current":-3.768995,"twenty":-6.13795,"median":-4.316397,"eighty":-2.200548,"marketCap":329790862},{"date":"2026-06-18","current":-4.468952,"twenty":-6.126808,"median":-4.313549,"eighty":-2.203948,"marketCap":391037737},{"date":"2026-06-26","current":-4.217685,"twenty":-6.117126,"median":-4.326091,"eighty":-2.204832,"marketCap":369051679},{"date":"2026-07-02","current":-3.99334,"twenty":-6.104164,"median":-4.314973,"eighty":-2.208169,"marketCap":349421271},{"date":"2026-07-10","current":-4.531768,"twenty":-6.104124,"median":-4.313549,"eighty":-2.214681,"marketCap":396534251},{"date":"2026-07-17","current":-4.092052,"twenty":-6.103378,"median":-4.308896,"eighty":-2.219277,"marketCap":358058651},{"date":"2026-07-24","current":-4.226659,"twenty":-6.103378,"median":-4.298726,"eighty":-2.232313,"marketCap":369836896},{"date":"2026-07-31","current":-3.903602,"twenty":-6.084882,"median":-4.292656,"eighty":-2.232313,"marketCap":341569107},{"date":"2026-08-07","current":-4.083078,"twenty":-6.074043,"median":-4.276491,"eighty":-2.23671,"marketCap":357273434},{"date":"2026-08-14","current":-4.663158,"twenty":-6.062913,"median":-4.289476,"eighty":-2.241319,"marketCap":406930442},{"date":"2026-08-21","current":-4.757173,"twenty":-6.046619,"median":-4.295552,"eighty":-2.242638,"marketCap":415134685}],"updateTime":1787485614243},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LXEO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643727044","title":"Lexeo Therapeutics Announces Regulatory Update and Registrational Trial Design for LX2006 Gene Therapy in Friedreich Ataxia","url":"https://stock-news.laohu8.com/highlight/detail?id=2643727044","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643727044?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:00","pubTimestamp":1781521200,"startTime":"0","endTime":"0","summary":"SUNRISE-FA 2 study parameters include LVMI primary endpoint, 6-month topline efficacy analysis, inclusion criteria focused on abnormal baseline LVMI and open-label trial design BLA supportive manufact","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/15/3311662/0/en/Lexeo-Therapeutics-Announces-Regulatory-Update-and-Registrational-Trial-Design-for-LX2006-Gene-Therapy-in-Friedreich-Ataxia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","FA","BK4535","BK4528","BK4539","BK4130","SAP","BK4023","LXEO","BK4139","BK4613","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636113858","title":"Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2636113858","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636113858?lang=en_us&edition=fundamental","pubTime":"2026-05-19 19:00","pubTimestamp":1779188400,"startTime":"0","endTime":"0","summary":"NEW YORK, May  19, 2026  (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, to","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/19/3297325/0/en/Lexeo-Therapeutics-to-Participate-in-the-2026-RBC-Capital-Markets-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128525929.USD","LU0128526141.USD","BK4535","LU0310800379.SGD","LXEO","BK4585","HCSG","LU0029874061.USD","BK4130","LU1267930573.SGD","FA","LABU","LU0708994859.HKD","BK4581","BK4539","XBI","BK4207","BK4137","LU0029864427.USD","BK4588","BK4139","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634213031","title":"Lexeo Therapeutics, Inc. (LXEO) Gets a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2634213031","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634213031?lang=en_us&edition=fundamental","pubTime":"2026-05-12 19:18","pubTimestamp":1778584705,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Luca Issi maintained a Buy rating on Lexeo Therapeutics, Inc. yesterday and set a price target of $20.00. The company’s shares ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lexeo-therapeutics-inc-lxeo-gets-a-buy-from-rbc-capital-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lexeo-therapeutics-inc-lxeo-gets-a-buy-from-rbc-capital-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029864427.USD","BK4139","LU0128525929.USD","BK4207","LXEO","LU0708994859.HKD","LU1267930573.SGD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634313802","title":"Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Lexeo Therapeutics, Inc. (LXEO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634313802","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634313802?lang=en_us&edition=fundamental","pubTime":"2026-05-12 02:20","pubTimestamp":1778523612,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioAge Labs, Inc. (BIOA) and Lexeo Therapeutics, I...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bioage-labs-inc-bioa-and-lexeo-therapeutics-inc-lxeo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-bioage-labs-inc-bioa-and-lexeo-therapeutics-inc-lxeo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","BK4588","BK4139","BK4007","LXEO","XLV","XBI","BK4581","LU0029874061.USD","BIOA","LU0128526141.USD","BK4137","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634239785","title":"Lexeo Therapeutics Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2634239785","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634239785?lang=en_us&edition=fundamental","pubTime":"2026-05-12 02:06","pubTimestamp":1778522760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LXEO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 14:06 ET (18:06 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634281598","title":"Lexeo Therapeutics reports Q1 EPS (25c), consensus (30c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634281598","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634281598?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:34","pubTimestamp":1778502861,"startTime":"0","endTime":"0","summary":"“We continued to make steady progress across our key priorities in the first quarter of 2026. As we work with the FDA to finalize the SUNRISE-FA 2 ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexeo-therapeutics-reports-q1-eps-25c-consensus-30c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexeo-therapeutics-reports-q1-eps-25c-consensus-30c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634283240","title":"Lexeo Therapeutics Q1 EPS $(0.25) Beats $(0.33) Estimate, Cash, Cash Equivalents And Investments Of $227.6M Expected To Provide Operational Runway Into 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2634283240","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634283240?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:21","pubTimestamp":1778498466,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics Q1 EPS $(0.25) Beats $(0.33) Estimate, Cash, Cash Equivalents And Investments Of $227.6M Expected To Provide Operational Runway Into 2028","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/LXEO","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634046288","title":"Lexeo Q1 FY26 net loss narrows to $20.2 million, or $0.25 a share","url":"https://stock-news.laohu8.com/highlight/detail?id=2634046288","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634046288?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:03","pubTimestamp":1778497404,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics posted a Q1 net loss of USD 20.2 million, narrowing from USD 32.7 million a year earlier, while loss per share improved to USD 0.25 from USD 0.99.Operating loss narrowed to USD 22.33 million from USD 33.81 million, as total operating expenses fell to USD 22.33 million from USD 33.81 million.R&D spend dipped to USD 15.7 million from USD 17.2 million, while G&A expense dropped to USD 6.63 million from USD 16.63 million.Cash, cash equivalents and investments totaled USD 227.6 million at March 31, with runway expected into 2028.Protocol and statistical analysis plan for SUNRISE-FA 2 pivotal trial for LX2006 were submitted to FDA in Q1, with final feedback expected in Q2 and trial initiation targeted for Q2.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL8PhfwR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BN0W2W23.USD","BK4588","SG9999014005.SGD","BK4139","SG9999014021.USD","LU0314104364.USD","LU2095319765.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","SG9999014013.SGD","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014039.USD","NDAQ","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634881812","title":"Press Release: Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2634881812","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634881812?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:00","pubTimestamp":1778497200,"startTime":"0","endTime":"0","summary":"SUNRISE-FA 2 open-label, pivotal trial protocol and SAP for LX2006 submitted to FDA in Q1 2026; Awaiting final FDA feedback. Multiple presentations highlighting progress across cardiac genetic medicine pipeline and optimized, Sf9-baculovirus AAV manufacturing platform to be presented at ASGCT 2026. Appointed Laura Sepp-Lorenzino, Ph.D. to Board of Directors. Cash, cash equivalents and investments of $227.6 million expected to provide operational runway into 2028. \"We continued to make steady progress across our key priorities in the first quarter of 2026. As we work with the FDA to finalize the SUNRISE--FA 2 pivotal study protocol, we are advancing site readiness and patient identification activities to ensure we are prepared to initiate the study promptly once the protocol is complete,\" said R. Nolan Townsend, Chief Executive Officer of Lexeo Therapeutics. \"We will also have a meaningful scientific presence at ASGCT this week, where we will share updates from our LX2006 program as wel","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4535","LXEO","BK4613","BK4023","BK4539","BK4585","FA","SAP","BK4139","BK4130","BK4528","CSF","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634464036","title":"Lexeo Therapeutics Inc  expected to post a loss of 31 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634464036","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634464036?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:20","pubTimestamp":1778271612,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics Inc  expected to post a loss of31cents a share - Earnings Preview Lexeo Therapeutics Inc LXEO.OQ LXEO.O is expected to  show no change in quarterly revenue when it reports  results ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L2KP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631350106","title":"Lexeo Therapeutics appoints Laura Sepp-Lorenzino to board","url":"https://stock-news.laohu8.com/highlight/detail?id=2631350106","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631350106?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:05","pubTimestamp":1777547139,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics appointed Laura Sepp-Lorenzino to board on April 28, 2026.Board named Sepp-Lorenzino to Science and Technology Committee.Sepp-Lorenzino will serve as director through 2028 annual meeting of stockholders.She has served as principal of genomic medicine consultancy GNMmeds since January 2025.Sepp-Lorenzino previously served as executive vice president, chief scientific officer at Intellia Therapeutics from May 2019 to January 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexeo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL4Vnv5Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4535","LU1861558580.USD","LXEO","BK4588","LU1861559042.SGD","NTLA","BK4556","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631635978","title":"Lexeo Therapeutics announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2631635978","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631635978?lang=en_us&edition=fundamental","pubTime":"2026-04-30 19:03","pubTimestamp":1777546994,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics scheduled 2026 annual stockholder meeting for June 25, 2026, to be held virtually.Shareholders will vote on election of three Class III directors: R. Nolan Townsend, Brenda Cooperstone, Paula HJ Cholmondeley.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexeo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL4Xgh4Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630978348","title":"Lexeo to present new gene therapy and AAV manufacturing data at ASGCT meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630978348","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630978348?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:15","pubTimestamp":1777324520,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics will present new data on cardiac gene therapy programs, neurologic work in Friedreich ataxia, and AAV manufacturing at ASGCT Annual Meeting in Boston on May 11-15, 2026.Manufacturing-focused presentations on AAVrh.10 process comparability, scale-up, and sequencing in release testing are scheduled for May 14-15, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDLk6tFn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","LXEO","IE00BN0W2T93.GBP","BK4585","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014013.SGD","NDAQ","SG9999014005.SGD","LU0314104364.USD","LU2095319765.USD","SG9999014039.USD","IE00BN0W2V16.EUR","BK4112","SG9999014021.USD","LU2210150020.SGD","BK4588","IE00BN0W2W23.USD","BK4139","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630348975","title":"Lexeo Therapeutics Announces Multiple Presentations at the 29TH American Society of Gene & Cell Therapy (Asgct) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2630348975","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630348975?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:15","pubTimestamp":1777324500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUABJWXNB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LXEO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625383969","title":"Lexeo CEO Richard Nolan Townsend disposes of 55,000 shares worth $313,137","url":"https://stock-news.laohu8.com/highlight/detail?id=2625383969","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625383969?lang=en_us&edition=fundamental","pubTime":"2026-04-08 04:55","pubTimestamp":1775595337,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics CEO Richard Nolan Townsend sold 55,000 common shares on April 6, 2026.Sale priced at weighted average USD 5.69 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lexeo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 07, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL3yxbXm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Lexeo CEO Richard Nolan Townsend disposes of 55,000 shares worth $313,137","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623067586","title":"Oppenheimer Reaffirms Their Buy Rating on Lexeo Therapeutics, Inc. (LXEO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623067586","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623067586?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:55","pubTimestamp":1774958119,"startTime":"0","endTime":"0","summary":"In a report released today, Leland Gershell from Oppenheimer reiterated a Buy rating on Lexeo Therapeutics, Inc., with a price target of $20.00. Ge...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-reaffirms-their-buy-rating-on-lexeo-therapeutics-inc-lxeo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-reaffirms-their-buy-rating-on-lexeo-therapeutics-inc-lxeo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXEO","OPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623958369","title":"Lexeo Therapeutics, Inc. (LXEO) Gets a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2623958369","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623958369?lang=en_us&edition=fundamental","pubTime":"2026-03-31 18:59","pubTimestamp":1774954778,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Luca Issi from RBC Capital maintained a Buy rating on Lexeo Therapeutics, Inc., with a price target of $20.00. The ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lexeo-therapeutics-inc-lxeo-gets-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lexeo-therapeutics-inc-lxeo-gets-a-buy-from-rbc-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0708994859.HKD","LU0128525929.USD","BK4139","BK4207","LXEO","LU0310800379.SGD","LU1267930573.SGD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623320154","title":"Lexeo Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2623320154","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623320154?lang=en_us&edition=fundamental","pubTime":"2026-03-31 07:59","pubTimestamp":1774915169,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryLexeo Therapeutics Inc LXEO.OQ reported a quarterly adjusted loss of 27 cents per share for the quarter ended","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nL8N40I28C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623320264","title":"Lexeo Therapeutics Advances Cardiac Gene Therapies, Strengthens Finances","url":"https://stock-news.laohu8.com/highlight/detail?id=2623320264","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623320264?lang=en_us&edition=fundamental","pubTime":"2026-03-31 07:52","pubTimestamp":1774914772,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics, Inc. ( ($LXEO) ) has provided an update. Lexeo Therapeutics reported fourth-quarter and full-year 2025 results on March 30, 202...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lexeo-therapeutics-advances-cardiac-gene-therapies-strengthens-finances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lexeo-therapeutics-advances-cardiac-gene-therapies-strengthens-finances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXEO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623329413","title":"Lexeo Therapeutics Q4 EPS $(0.27) Beats $(0.34) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2623329413","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623329413?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:30","pubTimestamp":1774902604,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics (NASDAQ:LXEO) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.34) by 21.28 percent. This is a 65.38 percent increase over losses of $(0.78) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51553286/lexeo-therapeutics-q4-eps-0-27-beats-0-34-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Lexeo Therapeutics Q4 EPS $(0.27) Beats $(0.34) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":45,"code":"91000000","status":"200"}]}}